title: Live attenuated vaccinia and other poxviruses as delivery systems: public health issues.
authors.affiliation: Virogenetics Corporation, Troy, New York 12180, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Perkus
authors.forename: J
authors.initials: J
authors.lastname: Taylor
authors.forename: J
authors.initials: J
authors.lastname: Tartaglia
authors.forename: S
authors.initials: S
authors.lastname: Pincus
authors.forename: E B
authors.initials: EB
authors.lastname: Kauffman
authors.forename: J A
authors.initials: JA
authors.lastname: Tine
authors.forename: E
authors.initials: E
authors.lastname: Paoletti
mesh_terms: D000818:Animals; D018150:Avipoxvirus / Q000254:growth & development / Q000276:immunology*; D005822:Genetic Vectors; D051379:Mice; D011817:Rabbits; D014613:Vaccines, Attenuated / Q000737:chemistry*; D017778:Vaccines, Combined / Q000737:chemistry* / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D014616:Vaccinia virus / Q000276:immunology*; D014765:Viral Vaccines / Q000737:chemistry*; D014779:Virus Replication
chemical_list: D014613:Vaccines, Attenuated; D017778:Vaccines, Combined; D014614:Vaccines, Synthetic; D014765:Viral Vaccines